BENJAMIN GLEASON: Open Payments
NPI 1922606854 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,468 in 111 payments from 18 companies in 2025. Trend: 2023 $2,248 · 2024 $2,553 · 2025 $2,468
Food & beverage: $2,468
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $1,047 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 17 | $356 |
| Novartis Pharmaceuticals Corporation | 8 | $206 |
| UCB, Inc. | 10 | $179 |
| LEO Pharma Inc. | 6 | $125 |
| Amgen Inc. | 3 | $82 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $81 |
| Botanix SB Inc | 3 | $75 |
| Organon LLC | 2 | $51 |
| Cipher Pharmaceuticals US LLC | 1 | $46 |
Products named: RINVOQ, SKYRIZI, ILUMYA, Bimzelx, COSENTYX, Winlevi, OTEZLA, SOFDRA.
Industry payments across NY — which companies pay providers there.
